05:34 PM EDT, 08/19/2025 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on August 15, 2025, sold 2,274 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,030,727. Following the Form 4 filing with the SEC, Poulton has control over a total of 50,178 common shares of the company, with 50,121 shares held directly and 57 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000090/xslF345X05/edgardoc.xml